| 发明名称 |
Use of an NMDA NR2B antagonist for treatment of depression. |
| 摘要 |
<p>The invention provides new methods for treating certain disorders resulting from neurodegeneration and for treating depression which comprise administration of NR2B subunit selective NMDA antagonists. The disorders that can be treating by the invention include hearing loss, vision loss, neurodegeneration caused by epileptic seizures, neurotoxin poisoning, Restless Leg Syndrome, multi-system atrophy, non-vascular headache, and depression.</p> |
| 申请公布号 |
EP1199068(A2) |
申请公布日期 |
2002.04.24 |
| 申请号 |
EP20010308295 |
申请日期 |
2001.09.28 |
| 申请人 |
PFIZER PRODUCTS INC. |
发明人 |
CHENARD, BERTRAND LEO;MENNITI, FRANK SAMUEL;SALTARELLI, MARIO DAVID |
| 分类号 |
A61K45/00;A61P25/24;A61K31/00;A61K31/05;A61K31/4015;A61K31/445;A61K31/451;A61K31/452;A61K31/4525;A61K31/453;A61K31/46;A61P25/00;A61P25/28;A61P27/00;A61P27/02;A61P27/06;A61P27/16;A61P43/00;(IPC1-7):A61K31/00 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
